Natalie Winters

“I absolutely will cooperate fully and testify before the Congress… I have nothing to hide.” What changed? Join @NatalieWinters

Fauci in 2022: “I am very happy to testify before any congressional oversight committee. I have nothing to hide. I can explain and validate everything that I’ve done. I’m going to do what I need to do, and that is cooperate fully, because we have nothing to hide at all.” Join @NatalieWinters

THEN: “I welcome oversight… I would be happy to cooperate.” NOW: Fauci pleaded the Fifth more than 100 times under congressional questioning. Join @NatalieWinters

Company disclosures show scientific advisers may hold stock, yet Fauci’s compensation and ownership remain hidden. Did he profit? Read the full investigation and subscribe free to support reporting they do not want you to see: https://nataliegwinters.substack.com/p/exc-fauci-secretly-joined-an-mrna Join @NatalieWinters

Then came the payday. Eli Lilly agreed to buy the company for up to $1.55 billion. A former ARPA-H official said the agency helped: “derisk their technology platform enough for this exit.” Join @NatalieWinters

In 2024, Biden’s ARPA-H awarded the company an initial $28.2 million, with up to $49 million available. . . . The program targeted: “existing and unknown viral threats” and viruses tied to: “emerging infections, and potential pandemics.” Its federally backed patents cover mRNA, modified nucleosides and lipid nanoparticles. Join @NatalieWinters

The startup was stacked with insiders. Its CFO was a former Biden White House COVID adviser. Its chief medical officer spent roughly 18 years at Fauci’s NIAID and helped oversee Moderna’s first COVID vaccine trial. Join @NatalieWinters

Fauci’s own résumé confirms: “Member, Scientific Advisory Group, Vaccine Company, Inc., 2023-present.” It does not disclose consulting fees, stock, options or other compensation. Join @NatalieWinters

EXCLUSIVE: Anthony Fauci quietly joined a stealth mRNA vaccine startup in 2023. Then the Biden administration awarded it more than $28 million to develop vaccines for viruses with pandemic potential. Now Eli Lilly is buying it for up to $1.55 billion. Join @NatalieWinters

If people maybe just heard one speech from Xi Jinping, they would see that the PRC is at a people's war with us, and I think President Trump matched that intensity with what he was talking about [in his recent speech]… CUSEF [the China-United States Exchange Foundation] is one of dozens of United Front groups that are actively working to undermine the United States. And CUSEF itself also runs these same trips not just for journalists, but for congressmen, former congressmen, think tank types (the Center for American Progress, the one that basically staffed the entire Obama administration), Congressional staffers (you want to talk about the degrees to which they control and really run American politics), and even, believe it or not, partnering with the Congressional Black Caucus Foundation to host a special delegation where they sent young Black Americans over to China to basically get exposed to Chinese propaganda. And they had testimonials from the students when they came back. One of them literally was praising China as a quote, ‘amazing communist country that was superior to the United States. Join @NatalieWinters

The identities were scattered across archived rosters, itineraries, biographies and internal reports. Now they are all in one place. Read the full investigation and see the documents here: https://nataliegwinters.substack.com/p/exc-leaked-document-names-mainstream Join @NatalieWinters

The report also tracked the stories produced after the trips. Clive Crook published: “Why China and the U.S. Can Be Capitalist Comrades” C100 wanted the delegates to carry its preferred view of China back into America’s most influential newsrooms. . . . Several delegates later became prominent opponents of tougher action against Beijing. David Brooks called Trump’s proposed tariffs: “The single worst policy idea on the table before us.” He dismissed the argument that tariffs were necessary to confront China. . . . Eugene Robinson attacked Trump’s trade war as an: “Ill-advised gambit.” He wrote that Xi Jinping could emerge as the “reasonable adult” in the confrontation between Washington and Beijing. . . . Financial Times columnist John Gapper later defended allowing Chinese-founded fast-fashion giant Shein to list in London despite scrutiny of its supply chains, labor practices and governance. His conclusion: Britain should allow the listing. Join @NatalieWinters

C100’s internal verdict: “The C-100 Leadership Delegation Program has had a visible impact on their understanding and perceptions of China.” It hoped participants would share their experiences with colleagues to shape “reporting and coverage of China.” Join @NatalieWinters

A Chinese academic congratulated the organizers for achieving exactly what the program was designed to do. Fudan University professor Shen Dingli told C100: “It is hard to speak on China without being to the country. You made the change!” Join @NatalieWinters

The New York Times’ Winnie O’Kelley returned with “several story ideas” and plans to: “Shape my staff across Asia in some different ways.” She also said: “I hope to add at least one business reporter in China.” Join @NatalieWinters

WNYC host Brian Lehrer said his perception of China changed: “In 100 ways.” Foreign Affairs editor Jonathan Tepperman returned with a “much deeper, more subtle and more nuanced sense” of China. He called it the best press trip he had taken. Join @NatalieWinters

Financial Times editor Gary Silverman said: “I don’t think that I will ever think or write about China in the future without reflecting on what I learned this week.” That is the influence operation describing its impact in the journalist’s own words. Join @NatalieWinters

The names are explosive. The internal after-action report is worse. Marked “Internal Use,” it recorded what journalists said after being escorted through Beijing, Shanghai and Hangzhou. The organizers treated changing their thinking as the measure of success. Join @NatalieWinters

• Clive Crook, Senior Editor, The Atlantic • John Gapper, Associate Editor and columnist, Financial Times • Winnie O’Kelley, Deputy Business Editor, The New York Times • Nicholas Goldberg, Editorial Pages Editor, Los Angeles Times . . . • Jonathan Tepperman, Managing Editor, Foreign Affairs • Gary Silverman, U.S. News Editor and Deputy Managing Editor, Financial Times • Charles Cook, publisher, Cook Political Report • Henry Finder, Editorial Director, The New Yorker . . . • John Byrne, Executive Editor, BusinessWeek • Adam Kushner, Executive Editor, National Journal • Rekha Basu, columnist, Des Moines Register • Brian Gallagher, Editorial Page Editor, USA TODAY Join @NatalieWinters

• Eugene Robinson, columnist and Associate Editor, Washington Post • Tavis Smiley, host, PBS and PRI • Ruth Marcus, columnist, Washington Post • Howard Fineman, Editorial Director, HuffPost . . . • Fred Hiatt, Editorial Page Editor and columnist, Washington Post • Clarence Page, columnist, Chicago Tribune • Brian Lehrer, host, WNYC • Rana Foroohar, Deputy Editor, Newsweek Join @NatalieWinters